Taysha Gene Therapies will add more than 200 jobs as part of an expansion in RTP. The company, based in Dallas, chose the Triangle over Dallas, Texas, for a 160,000 square foot facility which will serve as its manufacturing site. It will invest $75 million as part of the expansion. North Carolina’s Economic Investment Committee approved a state benefits package of more than $5 million for the project at a meeting earlier this week. Taysha joins a growing number of companies in the Triangle area focused on gene therapies. The site is expected to be completed and conducting hiring in the next three years.